---
schema_version: "secwatch.filing_event.v1"
accession: "0001906324-24-000030"
form_type: "8-K"
ticker: "QDEL"
cik: "0001906324"
company_name: "QuidelOrtho Corp"
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T13:49:58.421416+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# QuidelOrtho Q1 revenue $711M, GAAP loss $25.50/share; suspends 2024 guidance after new CEO

## Summary
- Total revenue $711M, down 16% YoY; ex-COVID revenue grew 5% as reported (6% constant currency).
- GAAP diluted loss per share $25.50 from $1.74B goodwill impairment; adjusted EPS $0.44 vs $1.80.
- Appointed Brian J. Blaser CEO effective May 6; suspended 2024 financial guidance.
- Cost reduction headcount cuts expected to deliver ~$100M annualized savings.
- Secured credit agreement amendment for additional flexibility through 2027.

## SEC filing metadata
- accession: 0001906324-24-000030
- form_type: 8-K
- ticker: QDEL
- cik: 0001906324
- company_name: QuidelOrtho Corp
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000030/0001906324-24-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000030/qdel-20240508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001906324-24-000030
- JSON: https://secwatch.observer/filing/0001906324-24-000030.json
- Plain text: https://secwatch.observer/filing/0001906324-24-000030.txt

## Key facts
- Earnings Releases
  QuidelOrtho Corp reported first quarter ended March 31, 2024 results: revenue $711 million, EPS GAAP diluted loss per share for the first quarter of 2024 was $25.50.
  - Period: first quarter ended March 31, 2024
  - Revenue: $711 million
  - EPS: GAAP diluted loss per share for the first quarter of 2024 was $25.50
  - Result: reported results
  source text: suspends 2024 financial guidance while it assesses business under new President and Chief Executive Officer - First Quarter 2024 Results and Recent Highlights • Revenue was $711 million, as reported: ◦ Non-respiratory revenue was flat at $574 million compared to the prior year period, as reported and in constant currency ▪ Excluding the one-time third-party
  evidence_url: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000030/0001906324-24-000030-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.